|
|
|
Cancer control in children : report on a study /
|
Hrodek, O.
|
c1983.
|
|
|
Cancer control knowledge into action /
|
|
c2006.
|
|
|
Cancer control knowledge into action : WHO guide for effective programmes. [Module 6], Policy and advocacy /
|
|
c2006-2008.
|
|
|
Cancer control opportunities in low- and middle-income countries
|
Institute of Medicine (U.S.). Committee on Cancer Control in Low- and Middle-Income Countries.
|
2006.
|
|
|
Diagnosis and treatment
|
|
2008.
|
|
|
Prevention
|
|
2007.
|
|
|
Prevention
|
|
2007.
|
|
|
Cancer control knowledge into action /
|
|
c2006.
|
|
|
Cancer cytogenetics
|
|
c2009.
|
|
|
The Cancer Degradome Proteases and Cancer Biology /
|
Edwards, Dylan.
|
2008.
|
|
|
Cancer diagnosis : new concepts and techniques /
|
|
c1982.
|
|
|
Cancer diagnosis in vitro using monoclonal antibodies /
|
|
c1988.
|
|
|
Cancer, diagnosis, treatment and prognosis/
|
Ackerman, Lauren Vedder, 1905.
|
1954.
|
|
|
Cancer, diagnostics, and chemotherapy : a reference manual /
|
Chernecky, Cynthia C.
|
c1991.
|
|
|
Cancer diognosis: new concepts and techniques/
|
Steckel, Richard J.
|
1982.
|
|
|
Cancer drug design and discovery
|
Neidle, Stephen.
|
c2008.
|
|
|
Anticancer drug development guide : preclinical screening, clinical trials, and approval /
|
|
c1997.
|
|
|
Tumor suppressor genes in human cancer/
|
|
2001.
|
|
|
Handbook of anticancer pharmacokinetics and pharmacodynamics /
|
|
c2004.
|
|
|
Cancer chemoprevention/
|
|
2005.
|
|
|
Biomarkers in breast cancer : molecular diagnostics for predicting and monitoring therapeutic effect/
|
|
2006.
|
|
|
Combination cancer therapy : modulators and potentiators/
|
|
2005.
|
|
|
Cancer chemoprevention /
|
|
c2004-c2005.
|
|
|
Bone metastasis : experimental and clinical therapeutics/
|
|
2005.
|
|
|
DNA repair in cancer therapy /
|
|
c2004.
|
|
|
Biomarkers in breast cancer : molecular diagnostics for predicting and monitoring therapeutic effect/
|
|
2006.
|
|
|
Oncogenomics handbook /
|
|
c2005.
|
|
|
Cytokines in the Genesis and Treatment of Cancer
|
Caligiuri, Michael A.
|
2007.
|
|
|
Cancer Drug Resistance
|
Teicher, Beverly A.
|
2006.
|
|
|
Deoxynucleoside Analogs In Cancer Therapy
|
Peters, Godefridus J.
|
2007.
|
|
|
Gene Therapy for Cancer
|
Hunt, Kelly K.
|
2007.
|
|
|
Apoptosis, Senescence, and Cancer
|
Gewirtz, David A.
|
2007.
|
|
|
Regional Cancer Therapy
|
Schlag, Peter M.
|
2007.
|
|
|
Bioinformatics in Cancer and Cancer Therapy
|
Gordon, Gavin J.
|
2009.
|
|
|
Bioinformatics in Cancer and Cancer Therapy
|
Gordon, Gavin J.
|
2009.
|
|
|
In Vivo Imaging of Cancer Therapy
|
Shields, Anthony F.
|
2007.
|
|
|
Molecular Targeting in Oncology
|
Kaufman, Howard L.
|
2008.
|
|
|
Cancer Proteomics From Bench to Bedside /
|
Daoud, Sayed S.
|
2008.
|
|
|
Antiangiogenic Agents in Cancer Therapy
|
Teicher, Beverly A.
|
2008.
|
|
|
Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response
|
Innocenti, Federico.
|
2009.
|
|
|
Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response
|
Innocenti, Federico.
|
2009.
|
|
|
Supportive Care in Cancer Therapy
|
Ettinger, David S.
|
2009.
|
|
|
Supportive Care in Cancer Therapy
|
Ettinger, David S.
|
2009.
|
|
|
CNS Cancer Models, Markers, Prognostic Factors, Targets, and Therapeutic Approaches /
|
Meir, Erwin G.
|
2009.
|
|
|
CNS Cancer Models, Markers, Prognostic Factors, Targets, and Therapeutic Approaches /
|
Meir, Erwin G.
|
2009.
|
|
|
Bladder Tumors: Molecular Aspects and Clinical Management /
|
Lokeshwar, Vinata B.
|
2011.
|
|
|
Bladder Tumors: Molecular Aspects and Clinical Management /
|
Lokeshwar, Vinata B.
|
2011.
|
|
|
Tumor Models in Cancer Research
|
Teicher, Beverly A.
|
2011.
|
|
|
Tumor Models in Cancer Research
|
Teicher, Beverly A.
|
2011.
|
|
|
Telomeres and Telomerase in Cancer
|
Hiyama, Keiko.
|
2009.
|
|
|
Telomeres and Telomerase in Cancer
|
Hiyama, Keiko.
|
2009.
|
|
|
Stem Cells and Cancer
|
Teicher, Beverly A.
|
2009.
|
|
|
Stem Cells and Cancer
|
Teicher, Beverly A.
|
2009.
|
|
|
Checkpoint Controls and Targets in Cancer Therapy
|
Siddik, Zahid H.
|
2009.
|
|
|
Checkpoint Controls and Targets in Cancer Therapy
|
Siddik, Zahid H.
|
2009.
|
|
|
Chemokine Receptors in Cancer
|
Fulton, Amy M.
|
2009.
|
|
|
Chemokine Receptors in Cancer
|
Fulton, Amy M.
|
2009.
|
|
|
mTOR Pathway and mTOR Inhibitors in Cancer Therapy
|
Polunovsky, Vitaly A.
|
2010.
|
|
|
mTOR Pathway and mTOR Inhibitors in Cancer Therapy
|
Polunovsky, Vitaly A.
|
2010.
|
|
|
Principles of Anticancer Drug Development
|
Garrett-Mayer, Elizabeth.
|
2011.
|
|
|
Principles of Anticancer Drug Development
|
Garrett-Mayer, Elizabeth.
|
2011.
|
|
|
The Tumor Microenvironment
|
Bagley, Rebecca G.
|
2010.
|
|
|
The Tumor Microenvironment
|
Bagley, Rebecca G.
|
2010.
|
|
|
Hormone Therapy in Breast and Prostate Cancer
|
Jordan, V. Craig.
|
2009.
|
|
|
Hormone Therapy in Breast and Prostate Cancer
|
Jordan, V. Craig.
|
2009.
|
|
|
Nitric Oxide (NO) and Cancer Prognosis, Prevention, and Therapy /
|
Bonavida, Benjamin.
|
2010.
|
|
|
Nitric Oxide (NO) and Cancer Prognosis, Prevention, and Therapy /
|
Bonavida, Benjamin.
|
2010.
|
|
|
Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy Molecular Mechanisms and Clinical Applications /
|
Bonetti, Andrea.
|
2009.
|
|
|
Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy Molecular Mechanisms and Clinical Applications /
|
Bonetti, Andrea.
|
2009.
|
|
|
DNA Topoisomerases and Cancer
|
Pommier, Yves.
|
2012.
|
|
|
DNA Topoisomerases and Cancer
|
Pommier, Yves.
|
2012.
|
|
|
Natural Products and Cancer Drug Discovery
|
Koehn, Frank E.
|
2013.
|
|
|
Natural Products and Cancer Drug Discovery
|
Koehn, Frank E.
|
2013.
|
|
|
Antibody-Drug Conjugates and Immunotoxins From Pre-Clinical Development to Therapeutic Applications /
|
Phillips, Gail Lewis.
|
2013.
|
|
|
Antibody-Drug Conjugates and Immunotoxins From Pre-Clinical Development to Therapeutic Applications /
|
Phillips, Gail Lewis.
|
2013.
|
|
|
Non-Hodgkin Lymphoma Prognostic Factors and Targets /
|
Quesenberry, Peter J.
|
2013.
|
|
|
Non-Hodgkin Lymphoma Prognostic Factors and Targets /
|
Quesenberry, Peter J.
|
2013.
|
|
|
Insulin-like Growth Factors and Cancer From Basic Biology to Therapeutics /
|
LeRoith, Derek.
|
2012.
|
|
|
Insulin-like Growth Factors and Cancer From Basic Biology to Therapeutics /
|
LeRoith, Derek.
|
2012.
|
|
|
Natural Killer T cells Balancing the Regulation of Tumor Immunity /
|
Terabe, Masaki.
|
2012.
|
|
|
Natural Killer T cells Balancing the Regulation of Tumor Immunity /
|
Terabe, Masaki.
|
2012.
|
|
|
Hypoxia and Cancer Biological Implications and Therapeutic Opportunities /
|
|
2014.
|
|
|
Hypoxia and Cancer Biological Implications and Therapeutic Opportunities /
|
|
2014.
|
|
|
Nuclear Signaling Pathways and Targeting Transcription in Cancer
|
|
2014.
|
|
|
Nuclear Signaling Pathways and Targeting Transcription in Cancer
|
|
2014.
|
|
|
Tumor Metabolome Targeting and Drug Development
|
|
2014.
|
|
|
Tumor Metabolome Targeting and Drug Development
|
|
2014.
|
|
|
BRAF Targets in Melanoma Biological Mechanisms, Resistance, and Drug Discovery /
|
|
2015.
|
|
|
BRAF Targets in Melanoma Biological Mechanisms, Resistance, and Drug Discovery /
|
|
2015.
|
|
|
Handbook of Anticancer Pharmacokinetics and Pharmacodynamics
|
|
2014.
|
|
|
Handbook of Anticancer Pharmacokinetics and Pharmacodynamics
|
|
2014.
|
|
|
PARP Inhibitors for Cancer Therapy
|
|
2015.
|
|
|
PARP Inhibitors for Cancer Therapy
|
|
2015.
|
|
|
Developments in T Cell Based Cancer Immunotherapies
|
|
2015.
|
|
|
Developments in T Cell Based Cancer Immunotherapies
|
|
2015.
|
|
|
PI3K-mTOR in Cancer and Cancer Therapy
|
|
2016.
|
|
|
PI3K-mTOR in Cancer and Cancer Therapy
|
|
2016.
|
|
|
STAT Inhibitors in Cancer
|
|
2016.
|
|
|
STAT Inhibitors in Cancer
|
|
2016.
|
|
|
Tumor Dormancy and Recurrence
|
|
2017.
|
Log in
Help
